Remove Atherosclerosis Remove Cancer Remove Cholesterol
article thumbnail

Beating the Odds: Inside the Tribe with a Near-Zero Rate of Heart Disease.

Dr. Paddy Barrett

It kills almost twice as many people globally when compared to all cancers combined. Share While the average Western male and female will develop advanced coronary artery disease by age 55 and 66, respectively, 85% of the Tsimane tribe population over 40 had no evidence of advanced atherosclerosis 2. Circulation. Adults: Fall 2019.

article thumbnail

Lipid-lowering effect and oral transport characteristics study of curculigoside

Frontiers in Cardiovascular Medicine

Statins are the primary drugs for treating hyperlipidemia or atherosclerosis, yet some patients remain unresponsive to them, and pregnant women are prohibited from taking statins. P-glycoprotein, breast cancer resistance protein, and efflux transporters are crucial components of the human intestinal cell line Caco-2.

article thumbnail

Avocados for the Heart; Cardiology's Sad State; CBD for Pulmonary Hypertension?

Heart 2023 Conference

Harvard University Heart Letter) A clinical polygenic risk score test for diseases ranging from atrial fibrillation (AFib) to breast cancer was piloted by scientists. In patients who are not taking statins, Esperion announced that bempedoic acid with or without ezetimibe (Nexletol/Nexlizet) can lower LDL cholesterol by more than 25%.

article thumbnail

If you have High LDL Cholesterol In Midlife This Is How You Should Think About It.

Dr. Paddy Barrett

If you have high LDL cholesterol and are unsure what that means for your risk of heart disease, this article is for you. Over the course of your lifetime, your LDL cholesterol will slowly increase. By midlife, the average male and female will see a significant rise in their LDL cholesterol. to 4 mmol (135 to 155 mg/dl).

article thumbnail

Longitudinal Assessment of Subclinical Arterial Inflammation in Patients Receiving Immune Checkpoint Inhibitors by Sequential [18F]FDG PET Scans

Circulation: Cardiovascular Imaging

BACKGROUND:Immune checkpoint inhibitors (ICIs), though revolutionary in cancer treatment, may accelerate atherosclerosis by inducing arterial inflammation. Cross-sectional analyses suggested a negative effect of cholesterol-lowering medication on arterial [18F]FDG uptake at follow-up. annually (95% CI, 1.7%3.3%;P=0.001

Cancer 40